Robert Graham Susman
Director · Immunovant, Inc.
- 2026
- May 1, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Graham Susman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M in IMVT purchases and sales in the last 12 months
- Jay S. Stout - $2.34M in IMVT purchases and sales in the last 12 months
- Melanie Gloria - $1.67M in IMVT purchases and sales in the last 12 months
- Tiago Girao - $1.41M in IMVT purchases and sales in the last 12 months
- Tuyl Christopher van - $1.17M in IMVT purchases and sales in the last 12 months
- Eric Venker - $581K in IMVT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Graham Susman?
Robert Graham Susman is a corporate insider, tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Robert Graham Susman last file a Form 4?
The most recent primary Form 4 on record is dated 1 May 2026, one of 2 filings going back to 2026.
Has Robert Graham Susman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($68K) across all tracked filings.
